Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Serum Therapy vs Levocetirizine in Chronic Urticaria
NCT06816784Phase 2Not yet recruiting
- Sponsor
- Sheikh Zayed Medical College
- Start
- Feb 2025
- Primary completion
- Jul 2025
- Modality
- Biologic (Biologic)
- Countries
- 1
01
Overview
A Phase 2 trial of autologous serum tears in chronic urticaria (CU), sponsored by Sheikh Zayed Medical College. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
autologous serum tears
03
Conditions
chronic urticaria (CU)
Beyond the preview
Go deeper on NCT06816784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06816784.